Nuwellis, Inc. (NASDAQ:NUWE) Shares Shorted: Short Interest Up 339.6% in SeptemberDefense World · Oct 13, 2026
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT SystemGlobeNewsWire · Oct 8, 2026
Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical ConferencesGlobeNewsWire · Oct 1, 2026
Nuwellis, Inc. (NASDAQ:NUWE) Sees Significant Decline in Short InterestDefense World · Sep 28, 2026
Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue OpportunityGlobeNewsWire · Sep 17, 2026
Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory AffairsGlobeNewsWire · Sep 16, 2026Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$23.80 | -$26.64 | Miss |
| May 12, 2026 | -$0.35 | -$0.73 | Miss |
| Mar 10, 2026 | -$0.55 | -$0.52 | Beat |
| Nov 12, 2025 | -$602.70 | $19.58 | Beat |
| Aug 14, 2025 | -$6.62 | -$21.35 | Miss |
| May 13, 2025 | -$6.61 | -$10.14 | Miss |